Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A randomized, double-blind, phase ii trial of paclitaxel plus carboplatin plus bevacizumab with or without apomab in patients with previously untreated, advanced-stage non-small cell lung cancer
apomab (Anti-DR5; PRO95780)
APM4074g
NCT00480831
advanced-stage non-small cell lung cancer
Phase 2
 
January 2014

Powered by ideaPoint, Inc.